TY  - GEN
AU  - Brassard,Maryse
AU  - Neraud,Barbara
AU  - Trabado,Séverine
AU  - Salenave,Sylvie
AU  - Brailly-Tabard,Sylvie
AU  - Borget,Isabelle
AU  - Baudin,Eric
AU  - Leboulleux,Sophie
AU  - Chanson,Philippe
AU  - Schlumberger,Martin
AU  - Young,Jacques
TI  - Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer
SN  - 1945-7197
PY  - 2011///1123
KW  - Adenocarcinoma, Follicular
KW  - blood
KW  - Adenocarcinoma, Papillary
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Blood Glucose
KW  - Calcium
KW  - Cross-Over Studies
KW  - Enzyme Inhibitors
KW  - therapeutic use
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Parathyroid Hormone
KW  - Piperidines
KW  - Proto-Oncogene Proteins c-ret
KW  - Quinazolines
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Testosterone
KW  - Thyroid Neoplasms
KW  - drug therapy
KW  - Treatment Outcome
KW  - Vitamin D
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1210/jc.2010-2771
ER  -